San Diego-Based Lab Discovers Coronavirus Vaccine in 3 Hours

Rebekah Sager
February 16, 2020 - 10:06 am

A San Diego-based biotech company says it created a vaccine for coronavirus on January 9, in three hours. Now, the scientists are trying to fast-track it onto the market. 

Inovio Pharmaceuticals is located in Sorrento Valley, has also created a vaccine for the Zika virus, the Middle East Respiratory Syndrome (MERS), and the vaccine for Ebola. 

Dr. Trevor Smith, who is the director of research and development at Inovio, told KVUE in an interview, "It's something we are trained to do, and the infrastructure is here and the expertise is in house."

The scientists are hoping the new vaccine will give the human body instructions to create the ability to attack in the form of T-cells and antibodies against the coronavirus. 

The drug has been tested on mice and guinea pigs, and Inovio says it will begin clinical trials in humans by early summer if they have FDA approval. 

Inovio's lead researcher is in Sweden meeting with the World Health Organization (WHO)  to come up with the best plan of attack against coronavirus, now officially referred to as COVID-19.